Skip to main content

CITADEL ADVISORS LLC

Position in OTLK — Outlook Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in OTLK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
18 quarters on record

Common Shares in OTLK Over Time

Shares Held

Position Value (USD)

Derivatives in OTLK

reported options exposure · as of Jun 30, 2026
CallValue
$265,689
CallShares
167,100
PutValue
$360,294
PutShares
226,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in OTLK

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $265,689 167,100
2026-06-30 $360,294 226,600
2026-03-31 $16,644 80,800
2026-03-31 $23,422 113,700
2025-12-31 $191,654 121,300
2025-12-31 $1,450,914 918,300
2025-09-30 $18,232 17,200
2025-09-30 $30,316 28,600
2025-03-31 $47,702 39,100
2024-12-31 $63,126 33,400
2024-12-31 $16,427 8,692
2024-12-31 $945 500
2024-09-30 $397,296 74,400
2023-09-30 $2,986 13,517
2023-03-31 $98,816 90,657
2022-12-31 $44,524 41,227
2022-09-30 $40,016 32,801
2022-06-30 $10,779 10,569
2022-03-31 $132,572 74,479
2021-12-31 $105,789 77,787
2021-09-30 $270,164 124,500
2021-06-30 $190,081 76,338
2021-03-31 $396,814 176,362
2020-12-31 $113,655 87,427